Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Immunohematology ; 40(1): 10-14, 2024 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-38739026

RESUMEN

This extraordinary case showcases the identification of a rare anti-Ena specificity that was assisted by DNA-based red blood cell antigen typing and collaboration between the hospital blood bank in the United States, the home blood center in Qatar, the blood center Immunohematology Reference Laboratory, as well as the American Rare Donor Program (ARDP) and the International Society for Blood Transfusion (ISBT) International Rare Donor Panel. Ena is a high-prevalence antigen, and blood samples from over 200 individuals of the extended family in Qatar were crossmatched against the patient's plasma with one compatible En(a-) individual identified. The ISBT International Rare Donor Panel identified an additional donor in Canada, resulting in a total of two En(a-) individuals available to donate blood for the patient.


Asunto(s)
Donantes de Sangre , Antígenos de Grupos Sanguíneos , Humanos , Antígenos de Grupos Sanguíneos/inmunología , Transfusión Sanguínea , Tipificación y Pruebas Cruzadas Sanguíneas/métodos , Qatar , Masculino , Femenino , Incompatibilidad de Grupos Sanguíneos/inmunología
2.
Immunohematology ; 40(2): 73-77, 2024 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-38910443

RESUMEN

This case report showcases an extraordinary collaboration to support the transfusion needs of a patient with a rare phenotype and long-standing anemia due to gastrointestinal bleeding. This report describes the Immunohematology Reference Laboratory testing and logistics of rare blood provision over an 11-year period, as well as a summary of the hematologic, gastroenterologic, and surgical interventions. This case illustrates how a strong collaboration among the clinical team, laboratory, blood center, and the rare donor community facilitated successful management of this patient's anemia until the patient could receive life-changing treatment.


Asunto(s)
Transfusión Sanguínea , Humanos , Masculino , Anemia/terapia , Anemia/sangre , Femenino , Hemorragia Gastrointestinal/terapia , Bancos de Sangre , Isoanticuerpos/sangre , Isoanticuerpos/inmunología , Persona de Mediana Edad
3.
Vox Sang ; 118(9): 763-774, 2023 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-37608544

RESUMEN

BACKGROUND AND OBJECTIVES: Human neutrophil antigens (HNAs) are categorized into five systems: HNA-1 to HNA-5. Given the importance of neutrophils in immunity, we sought to create awareness of the role of HNA diagnostic services in managing immune neutropenia and transfusion-related acute lung injury. To provide health communities all around the world with access to these services, we conducted a survey to create a directory of these HNA diagnostic services. MATERIALS AND METHODS: An Excel table-based survey was created to capture information on the laboratory's location and was emailed to 55 individuals with known or possible HNA investigation activity. The collected data were then summarized and analysed. RESULTS: Of contacted laboratories, the surveys were returned from 23 (38.2%) laboratories; 17 have already established HNA diagnostic (of them 12 were regular participants of the International Granulocyte Immunobiology Workshop [ISBT-IGIW]), 4 laboratories were in the process of establishing their HNA investigation and the remaining 2 responder laboratories, did not conduct HNA investigations. In established laboratories, investigation for autoimmune neutropenia (infancies and adults) was the most frequently requested, and antibodies against HNA-1a and HNA-1b were the most commonly detected. CONCLUSION: The directory of survey respondents provides a resource for health professionals wanting to access HNA diagnostic services. The present study offers a comprehensive picture of HNA diagnostics (typing and serology), identifying weak points and areas for improvement for the first time. Identifying more laboratories involved in HNA diagnostics with limited access to international societies in the field will globally improve HNA diagnostics.


Asunto(s)
Neutropenia , Neutrófilos , Adulto , Humanos , Granulocitos , Anticuerpos , Encuestas y Cuestionarios
4.
Vox Sang ; 117(11): 1332-1344, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36121188

RESUMEN

BACKGROUND AND OBJECTIVES: Under the ISBT, the Working Party (WP) for Red Cell Immunogenetics and Blood Group Terminology is charged with ratifying blood group systems, antigens and alleles. This report presents the outcomes from four WP business meetings, one located in Basel in 2019 and three held as virtual meetings during the COVID-19 pandemic in 2020 and 2021. MATERIALS AND METHODS: As in previous meetings, matters pertaining to blood group antigen nomenclature were discussed. New blood group systems and antigens were approved and named according to the serologic, genetic, biochemical and cell biological evidence presented. RESULTS: Seven new blood group systems, KANNO (defined numerically as ISBT 037), SID (038), CTL2 (039), PEL (040), MAM (041), EMM (042) and ABCC1 (043) were ratified. Two (039 and 043) were de novo discoveries, and the remainder comprised reported antigens where the causal genes were previously unknown. A further 15 blood group antigens were added to the existing blood group systems: MNS (002), RH (004), LU (005), DI (010), SC (013), GE (020), KN (022), JMH (026) and RHAG (030). CONCLUSION: The ISBT now recognizes 378 antigens, of which 345 are clustered within 43 blood group systems while 33 still have an unknown genetic basis. The ongoing discovery of new blood group systems and antigens underscores the diverse and complex biology of the red cell membrane. The WP continues to update the blood group antigen tables and the allele nomenclature tables. These can be found on the ISBT website (http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/).


Asunto(s)
Antígenos de Grupos Sanguíneos , COVID-19 , Eritrocitos , Humanos , Antígenos de Grupos Sanguíneos/genética , Transfusión Sanguínea , Inmunogenética , Pandemias , Eritrocitos/inmunología
5.
Blood ; 132(11): 1198-1207, 2018 09 13.
Artículo en Inglés | MEDLINE | ID: mdl-30026182

RESUMEN

Rh alloimmunization remains a challenge for patients with sickle cell disease (SCD) despite transfusion of serologic Rh C, E, and K antigen-matched red cells. Inheritance of altered RH alleles contributes to the prevalence of Rh antibodies after blood transfusion in patients with SCD and explains approximately one-third of cases. The remainder seem to be stimulated by altered Rh proteins on African American donor red cells. Matching patients with donors on the basis of RH genotype may mitigate Rh alloimmunization, but the feasibility and resources required are not known. We compared RH allele frequencies between patients with SCD (n = 857) and African American donors (n = 587) and showed that RH allele frequencies are similar. Overall, 29% of RHD and 53% of RHCE alleles are altered in patients and African American donors. We modeled RH genotype matching compared with serologic Rh D, C, and E, along with K antigen matching, and found that approximately twice the number of African American donors would be required for RH genotype vs Rh serologic matching at our institution. We demonstrated that African American donor recruitment is necessary to maintain an adequate supply of C-, E-, and K-negative donor units to avoid depleting the Rh-negative (RhD-) blood supply. Our results suggest that prophylactic RH genetic matching for patients with SCD is feasible with a donor pool comprised primarily of African-Americans and would optimize the use of our existing minority donor inventory. The current cost of RH genotyping all minority donors and management of the data remain limiting factors.


Asunto(s)
Alelos , Anemia de Células Falciformes/genética , Frecuencia de los Genes , Genotipo , Sistema del Grupo Sanguíneo Rh-Hr/genética , Negro o Afroamericano , Anemia de Células Falciformes/terapia , Transfusión Sanguínea , Femenino , Humanos , Masculino , Reacción a la Transfusión/genética , Reacción a la Transfusión/prevención & control , Población Blanca
6.
Immunohematology ; 36(2): 58-59, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32667818

RESUMEN

CONCLUSIONS: This update of the RAPH blood group system (Hayes M. RAPH blood group system. Immunohematology 2014;30:6-10) reports no new alleles. The RAPH blood group system (International Society of Blood Transfusion system 25) consists of a single anti-gen (MER2) expressed on CD151, a member of the tetraspanin family of proteins. CD151 regulates interactions with laminin-binding integrins α3ß1, α6ß1, α6ß4, and α7ß1 and is expressed on red blood cells as well as many other tissues and cancer types. Lack of the RAPH protein is associated with nephropathy with pretibial epidermolysis bullosa and deafness.


Asunto(s)
Antígenos de Grupos Sanguíneos/inmunología , Antígenos CD , Adhesión Celular , Humanos , Integrina alfa3beta1 , Tetraspanina 24
7.
Immunohematology ; 36(4): 146-151, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33544620

RESUMEN

CONCLUSIONS: The D antigen is highly immunogenic and may cause alloimmunization to occur after blood transfusion or pregnancy. Some RHD variant alleles express a D antigen that is missing one or more epitopes, thus putting a presumed D+ patient at risk for alloanti-D and hemolytic disease of the fetus and newborn. It is generally accepted that individuals who have a serologic weak D phenotype due to one of three alleles common in Caucasians, RHD*weak D types 1, 2, or 3, are not at risk for alloimmunization. In this study, blood samples from 46 obstetrics patients from a local health system were identified based on discrepant results between automated gel and manual tube testing (n = 20) or based on presentation with a serologic weak D phenotype (n = 26). RHD genotyping was performed using commercial and laboratory-developed tests. Of the 26 serologic weak D samples, 18 (69.2%) were found to carry alleles RHD*weak D type 1, 2, or 3. The remaining eight samples (30.8%) were found to carry partial D alleles. Of the 20 samples submitted because of D typing discrepancy, 7 (35%) carried alleles RHD*weak D type 1, 2, or 3, while 13 (65%) carried partial RHD alleles. This report summarizes the findings of one hospital system and its approach to integrating RHD genotyping into its assessment of risk of alloimmunization in obstetrics patients. It demonstrates that individuals with partial RHD alleles can present with serologic weak D phenotype, such that, without RHD genotyping, these individuals may not be identified as candidates for Rh immune globulin. The study also demonstrates that use of two methods (automated gel and tube testing) allows for identification of partial D cases that would otherwise be missed. I.


Asunto(s)
Genotipo , Técnicas de Genotipaje , Isoanticuerpos/inmunología , Obstetricia/métodos , Sistema del Grupo Sanguíneo Rh-Hr/genética , Sistema del Grupo Sanguíneo Rh-Hr/inmunología , Globulina Inmune rho(D)/genética , Globulina Inmune rho(D)/inmunología , Alelos , Femenino , Humanos , Recién Nacido , Fenotipo , Embarazo
8.
Curr Opin Hematol ; 26(6): 480-487, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31490317

RESUMEN

PURPOSE OF REVIEW: To summarize the most recent scientific progress in transfusion medicine genomics and discuss its role within the broad genomic precision medicine model, with a focus on the unique computational and bioinformatic aspects of this emergent field. RECENT FINDINGS: Recent publications continue to validate the feasibility of using next-generation sequencing (NGS) for blood group prediction with three distinct approaches: exome sequencing, whole genome sequencing, and PCR-based targeted NGS methods. The reported correlation of NGS with serologic and alternative genotyping methods ranges from 92 to 99%. NGS has demonstrated improved detection of weak antigens, structural changes, copy number variations, novel genomic variants, and microchimerism. Addition of a transfusion medicine interpretation to any clinically sequenced genome is proposed as a strategy to enhance the cost-effectiveness of precision genomic medicine. Interpretation of NGS in the blood group antigen context requires not only advanced immunohematology knowledge, but also specialized software and hardware resources, and a bioinformatics-trained workforce. SUMMARY: Blood transfusions are a common inpatient procedure, making blood group genomics a promising facet of precision medicine research. Further efforts are needed to embrace transfusion bioinformatic challenges and evaluate its clinical utility.


Asunto(s)
Almacenamiento de Sangre , Bancos de Sangre , Genómica , Medicina de Precisión , Medicina Transfusional , Bancos de Sangre/normas , Transfusión Sanguínea/métodos , Transfusión Sanguínea/normas , Biología Computacional/métodos , Genómica/métodos , Humanos , Medicina de Precisión/métodos , Medicina de Precisión/normas , Investigación , Medicina Transfusional/métodos , Medicina Transfusional/normas , Almacenamiento de Sangre/métodos
9.
J Neurovirol ; 25(3): 313-323, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30610741

RESUMEN

We evaluated white matter microstructure integrity in perinatally HIV-infected (PHIV) youths receiving cART compared to age- and gender-matched healthy youths through DTI metrics using voxel-based morphometry (VBM). We investigated 14 perinatally HIV-infected patients (age 17.9 ± 2.5 years) on cART and 17 healthy youths (HC) (age 18.0 ± 3.0 years) using a 3T MRI scanner. Four DTI-derived metrics were fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). Statistical analysis was done with voxel-based analysis of covariance (ANCOVA), with age and gender as covariates. Region-of-interest secondary analyses in statistically significant regions were also performed. Regional increases in FA in the PHIV youths were found in left middle frontal gyrus, right precuneus, right lingual gyrus, and left supramarginal gyrus. Increased MD was found in the right precentral gyrus while decreased MD was found in the white matter of the right superior parietal lobule and right inferior temporal gyrus/fusiform gyrus. Regions of increased/decreased RD overlapped with regions of increased/decreased MD. Both increased and decreased AD were found in three to four regions respectively. The regional FA, MD, RD, and AD values were consistent with the voxel-based analysis findings. The findings are mostly consistent with previous literature, but increased FA has not been previously reported for perinatally HIV-infected youths. Potentially early and prolonged therapy in our population may have contributed to this new finding. Both toxicity of antiretroviral therapy and indolent infection must be considered as causative factors in the DTI metric changes that we have observed.


Asunto(s)
Encéfalo/diagnóstico por imagen , Infecciones por VIH/diagnóstico por imagen , Sustancia Blanca/diagnóstico por imagen , Adolescente , Antirretrovirales/uso terapéutico , Encéfalo/patología , Encéfalo/virología , Imagen de Difusión Tensora/métodos , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/patología , Humanos , Procesamiento de Imagen Asistido por Computador , Transmisión Vertical de Enfermedad Infecciosa , Masculino , Sustancia Blanca/patología , Sustancia Blanca/virología
10.
Vox Sang ; 114(1): 95-102, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30421425

RESUMEN

BACKGROUND AND OBJECTIVES: The International Society of Blood Transfusion (ISBT) Working Party for Red Cell Immunogenetics and Blood Group Terminology meets in association with the ISBT congress and has met three times since the last report: at the international meetings held in Dubai, United Arab Emirates, September 2016 and Toronto, Canada, June 2018; and at a regional congress in Copenhagen, Denmark, June 2017 for an interim session. METHODS: As in previous meetings, matters pertaining to blood group antigen nomenclature and classification were discussed. New blood group antigens were approved and named according to the serologic and molecular evidence presented. RESULTS AND CONCLUSIONS: Fifteen new blood group antigens were added to eight blood group systems. One antigen was made obsolete based on additional data. Consequently, the current total of blood group antigens recognized by the ISBT is 360, of which 322 are clustered within 36 blood groups systems. The remaining 38 antigens are currently unassigned to a known system. Clinically significant blood group antigens continue to be discovered, through serology/sequencing and/or recombinant or genomic technologies.


Asunto(s)
Transfusión Sanguínea , Congresos como Asunto , Inmunogenética , Terminología como Asunto , Canadá , Dinamarca , Humanos , Sociedades Científicas , Emiratos Árabes Unidos
11.
Immunohematology ; 35(4): 149-153, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31935331

RESUMEN

CONCLUSIONS: The ABO blood group system is the most clinically significant system in transfusion medicine. Although serologic typing for ABO antigens is routine and reliable, molecular methods can be used to predict an ABO type in the absence of a blood specimen as well as to investigate ABO typing discrepancies often caused by ABO subgroups that cause weakened antigen expression, weak or missing serum reactivity, and/or extra red blood cell reactivity. By detecting single nucleotide variants that are hallmarks of the major ABO alleles, low-resolution genotyping methods can be used to make allele assignments and predict phenotypes. This approach has become a dependable tool, initially to resolve typing discrepancies identified in blood banks and donor centers and, more recently, to predict the ABO group in bone marrow transplant donors and in deceased donors of solid organs. The aim of this report is to compare two different low-resolution polymerase chain reaction (PCR)-based methods: a PCRrestriction fragment length polymorphism (RFLP) implemented based on a publication and a commercially available TaqManbased sequence-specific primer-PCR for resolution of ABO typing discrepancies. Fifty-six peripheral blood samples from 31 patients and 25 blood donors were used to isolate genomic DNA and perform genotyping. Results of 49 of the 56 samples (87.5%) were concordant between methods, three samples yielded an unexpected banding pattern on the PCR-RFLP method, and four sample results were discordant between assays. The discordances all involved group A versus A2 discrepancies. Sanger sequencing was used as a high-resolution genotyping method to resolve discrepancies between the two low-resolution methods. This study demonstrates that, in the majority of cases, a low-resolution genotyping method can resolve an ABO discrepancy. Although there is no U.S. Food and Drug Administration-approved genotyping method for ABO determination, molecular testing for investigation of discrepancies is a useful tool for blood banks and transplant programs.


Asunto(s)
Tipificación y Pruebas Cruzadas Sanguíneas , Sistema del Grupo Sanguíneo ABO , Alelos , Genotipo , Humanos , Reacción en Cadena de la Polimerasa
12.
Transfusion ; 58(1): 196-199, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29047116

RESUMEN

BACKGROUND: Mutation in the KLF1 gene is the cause of the In(Lu) (Inhibitor of Lutheran) Lu(a-b-) phenotype and more than 60 alleles have been associated with this phenotype. Here we describe findings from investigation of seven cases: six presenting with a Lu(a-b-) phenotype including the historical index case and one referred from a patient with chronic anemia. STUDY DESIGN AND METHODS: Serologic testing was by standard methods. DNA testing included amplification and sequencing of KLF1 and LU coding regions. A StuI polymerase chain reaction-restriction fragment length polymorphism was designed to target c.304T>C in KLF1. RESULTS: Five different KLF1 alleles were identified. Three are new: KLF1*90A (p.Trp30Ter), KLF*911A (p.Thr304Lys), and KLF1*304C,318G (p. Ser102Pro, Tyr106Ter) present in two unrelated individuals. Two, including the index case, had c.954dupG (p.Arg319Glufs*34), that is, KLF1*BGM06. The child with unexplained anemia had c.973G>A (p.Glu325Lys), associated with congenital dyserythropoietic anemia. The common c.304T>C was found in two of the seven samples investigated and in 60 of 100 blood donors. CONCLUSION: Mutations in KLF1 are pleiotropic and although most are benign, others are associated with hematologic abnormalities. We report three new KLF1 alleles associated with benign In(Lu) and document both the molecular basis of the original In(Lu) phenotype using a frozen sample stored for more than 50 years and the cause of unexplained anemia in a child. We also confirm previous observations that c.304C (p.102Pro) is not, by itself, associated with an In(Lu) phenotype in donors self-identified as U.S. minorities.


Asunto(s)
Pleiotropía Genética , Factores de Transcripción de Tipo Kruppel/genética , Sistema del Grupo Sanguíneo Lutheran/genética , Mutación Missense , Mutación Puntual , Adolescente , Adulto , Alelos , Anemia/genética , Anemia Diseritropoyética Congénita/genética , Donantes de Sangre , Conservación de la Sangre , Niño , Criopreservación , Femenino , Estudios de Asociación Genética , Humanos , Isoanticuerpos/sangre , Isoanticuerpos/inmunología , Sistema del Grupo Sanguíneo Lutheran/sangre , Sistema del Grupo Sanguíneo Lutheran/inmunología , Masculino , Persona de Mediana Edad , Análisis de Secuencia de ADN
13.
Transfusion ; 57(11): 2804-2808, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-28815618

RESUMEN

BACKGROUND: Only a few genetic variants have been reported in regulatory elements of blood group genes. Most of them affect GATA motifs, binding sites for the GATA-1 transcription factor. STUDY DESIGN AND METHODS: Samples from two patients and one donor with unusual or discrepant serology for ABO, RhD, and RhCE antigens were analyzed by DNA sequencing. Analyzed regions included the coding sequence and portions of regulatory elements. The effect of some variants on gene expression was evaluated in reporter gene assays. RESULTS: Three new alleles were identified. Their key variants are located in the ABO Intron 1 enhancer, the RHD proximal promoter, and the RHCE proximal promoter. IVS1 + 5859A was found in an African American patient with a group O forward type and a group B reverse type. 5'UTR-115C was the only RHD variant sequence found in a mixed-race black and Caucasian prenatal patient showing mixed-field agglutination with anti-D. 5'UTR-83T was found in several black donors and patients in the context of the genetically related RHCE*ceBI and RHCE*ceSM alleles. Reporter assays of promoter constructs including 5'UTR-115C or 5'UTR-83T showed a significant reduction in RH gene expression. CONCLUSION: Three new alleles in the ABO, RHD, and RHCE genes consist of single-nucleotide changes within GATA motifs, emphasizing the key role of GATA transcription factors in the expression of blood group genes.


Asunto(s)
Antígenos de Grupos Sanguíneos/genética , Factores de Transcripción GATA/fisiología , Variación Genética , Motivos de Nucleótidos/fisiología , Secuencias Reguladoras de Ácidos Nucleicos , Sistema del Grupo Sanguíneo ABO , Negro o Afroamericano , Alelos , Regulación de la Expresión Génica , Humanos , Regiones Promotoras Genéticas , Sistema del Grupo Sanguíneo Rh-Hr/genética , Análisis de Secuencia de ADN
14.
Immunohematology ; 38(4): 142, 2022 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-36789460
15.
Magn Reson Med ; 75(1): 42-51, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25599891

RESUMEN

PURPOSE: To implement an accelerated five-dimensional (5D) echo-planar J-resolved spectroscopic imaging sequence combining 3 spatial and 2 spectral encoding dimensions and to apply the sequence in human brain. METHODS: An echo planar readout was used to acquire a single spatial and a single spectral dimension during one readout. Nonuniform sampling was applied to the two phase-encoded spatial directions and the indirect spectral dimension. Nonlinear reconstruction was used to minimize the ℓ1-norm or the total variation and included a spectral mask to enhance sparsity. Retrospective reconstructions at multiple undersamplings were performed in phantom. Ten healthy volunteers were scanned with 8× undersampling and compared to a fully sampled single slice scan. RESULTS: Retrospective reconstruction of fully sampled phantom data showed excellent quality at 4×, 8×, 12×, and 16× undersampling using either reconstruction method. Reconstruction of prospectively acquired in vivo scans with 8× undersampling showed excellent quality in the occipito-parietal lobes and good quality in the frontal lobe, consistent with the fully sampled single slice scan. CONCLUSION: By utilizing nonuniform sampling with nonlinear reconstruction, 2D J-resolved spectra can be acquired over a 3D spatial volume with a total scan time of 20 min, which is reasonable for in vivo studies.


Asunto(s)
Algoritmos , Encéfalo/metabolismo , Imagen Eco-Planar/métodos , Interpretación de Imagen Asistida por Computador/métodos , Imagenología Tridimensional/métodos , Imagen Molecular/métodos , Adulto , Encéfalo/anatomía & histología , Femenino , Humanos , Aumento de la Imagen/métodos , Masculino , Proyectos Piloto , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
16.
J Genet Couns ; 25(2): 385-94, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26306685

RESUMEN

Genetic literacy is essential for the effective integration of genomic information into healthcare; yet few recent studies have been conducted to assess the current state of this knowledge base. Participants in the Coriell Personalized Medicine Collaborative (CPMC), a prospective study assessing the impact of personalized genetic risk reports for complex diseases and drug response on behavior and health outcomes, completed genetic knowledge questionnaires and other surveys through an online portal. To assess the association between genetic knowledge and genetic education background, multivariate linear regression was performed. 4 062 participants completed a genetic knowledge and genetic education background questionnaire. Most were older (mean age: 50), Caucasian (90 %), female (59 %), highly educated (69 % bachelor's or higher), with annual household income over $100 000 (49 %). Mean percent correct was 76 %. Controlling for demographics revealed that health care providers, participants previously exposed to genetics, and participants with 'better than most' self-rated knowledge were significantly more likely to have a higher knowledge score (p < 0.001). Overall, genetic knowledge was high with previous genetic education experience predictive of higher genetic knowledge score. Education is likely to improve genetic literacy, an important component to expanded use of genomics in personalized medicine.


Asunto(s)
Competencia Clínica , Conducta Cooperativa , Genética/educación , Alfabetización en Salud , Medicina de Precisión , Adulto , Anciano , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Prospectivos , Encuestas y Cuestionarios
17.
Immunohematology ; 32(3): 91-95, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27834480

RESUMEN

The Kidd blood group on the red blood cell (RBC) glycoprotein urea transporter-B has a growing number of weak and null alleles in its gene SLC14A1 that are emerging from more widespread genotyping of blood donors and patients. We investigated a 64-year-old Caucasian woman of Polish-Czech descent who developed anti-Jkb detected in solid-phase RBC adherence testing within 12 days after 7 units of RBCs were transfused. Her RBCs subsequently typed Jk(a+b­) by licensed reagents and human antisera. Nevertheless, in RBC genotyping (BioArray HEA BeadChip, Immucor, Warren, NJ) performed in our transfusion service on all patients with alloantibodies, her Kidd typing was JK*A/JK*B based on the Jka/Jkb single nucleotide polymorphism in exon 9 (c.838G>A, p.Asp280Asn). Genomic analysis and cDNA sequencing of her JK*B allele revealed a novel single-nucleotide deletion of c.1038G in exon 11, predicting a frameshift and premature stop (p.Thr346Thrfs*5) after translation of nearly 90 percent of the expressed exons 4­11. This allele has been provisionally named JK*02N.14, subject to approval by the International Society of Blood Transfusion Working Party. The site of this variant is closer to the C-terminus than that of any allele associated with the Jk(a­b­) phenotype reported to date. Routine genotyping of patients with RBC alloantibodies can reveal variants posing potential risk of alloimmunization. Continuing investigation of Kidd variants may shed light on the structure of Kidd antigens and the function of urea transporter-B.


Asunto(s)
Isoanticuerpos/sangre , Sistema del Grupo Sanguíneo de Kidd/genética , Proteínas de Transporte de Membrana/genética , Mutación Puntual , Eliminación de Secuencia , Alelos , Especificidad de Anticuerpos , Incompatibilidad de Grupos Sanguíneos/sangre , Tipificación y Pruebas Cruzadas Sanguíneas , Codón sin Sentido/genética , Femenino , Mutación del Sistema de Lectura , Humanos , Isoanticuerpos/biosíntesis , Isoanticuerpos/inmunología , Proteínas de Transporte de Membrana/química , Proteínas de Transporte de Membrana/inmunología , Persona de Mediana Edad , Modelos Moleculares , Análisis de Secuencia por Matrices de Oligonucleótidos , Fenotipo , Polimorfismo de Nucleótido Simple , Hemorragia Posoperatoria/terapia , Conformación Proteica , Análisis de Secuencia de ADN , Reacción a la Transfusión , Transportadores de Urea
18.
Transfusion ; 55(9): 2095-103, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25808011

RESUMEN

BACKGROUND: Hemolytic disease of the fetus and newborn, classically caused by maternal-fetal incompatibility of the Rh blood group D antigen, can be prevented by RhIG prophylaxis. While prophylactic practices for pregnant women with serologic weak D phenotypes vary widely, RHD genotyping could provide clear guidance for management. This analysis evaluated the financial implications of using RHD genotyping to guide RhIG prophylaxis among pregnant females. STUDY DESIGN AND METHODS: A Markov-based model was constructed to evaluate the costs of RHD genotyping for pregnant females with serologic weak D phenotypes to inform RhIG prophylaxis. Using a comparison strategy of managing these women conservatively as D-, direct medical costs were assessed over 10- and 20-year periods for a simulated population of US women. One-way and probabilistic sensitivity analyses were used to assess the robustness of conclusions. RESULTS: Using base-case variables, RHD genotyping for pregnant women with serologic weak D phenotypes is expected to marginally reduce overall costs. RHD genotyping these patients, rather than conservatively managing them as D-, would be cost-saving when the cost of genotyping is below $256. Genotyping would decrease net costs among non-Hispanic Caucasian females (-$0.17/pregnancy), but would increase costs among non-Hispanic African Americans (+$0.51/pregnancy), non-Hispanic American Indian/Alaskans (+$0.10/pregnancy), and Hispanics (+$0.37/pregnancy). Incorporating RHD genotyping would not significantly impact costs among Asians and Hawaiians/Pacific Islanders. CONCLUSIONS: Using RHD genotyping to guide RhIG prophylaxis among pregnant women with serologic weak D phenotypes may be clinically beneficial without increasing overall costs.


Asunto(s)
Eritroblastosis Fetal , Técnicas de Genotipaje/economía , Modelos Económicos , Sistema del Grupo Sanguíneo Rh-Hr/genética , Adulto , Costos y Análisis de Costo , Eritroblastosis Fetal/economía , Eritroblastosis Fetal/genética , Eritroblastosis Fetal/prevención & control , Femenino , Técnicas de Genotipaje/métodos , Humanos , Cadenas de Markov , Embarazo , Estados Unidos
20.
Immunohematology ; 31(3): 103-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26829175

RESUMEN

Duffy antigens are important in immunohematology. the reference allele for the Duffy gene (FY) is FY*02, which encodes Fy(b). An A>G single nucleotide polymorphism (SNP) at coding nucleotide (c.) 125 in exon 2 defines the FY*01 allele, which encodes the antithetical Fy(a). A C>T SNP at c.265 in the FY*02 allele is associated with weakening of Fy(b) expression on red blood cells (R BCs) (called Fy(x)). until recently, this latter change had not been described on a FY*01 background allele. Phenotype-matched units were desired for a multi-transfused Vietnamese fetus with α-thalassemia. Genotyping of the fetus using a microarray assay that interrogates three SNPs (c.1-67, c.125, and c.265) in FY yielded indeterminate results for the predicted Duffy phenotype. Genomic sequencing of FY exon 2 showed that the fetal sample had one wild-type FY*01 allele and one new FY*01 allele with the c.265C>T SNP, which until recently had only been found on the FY*02 allele. Genotyping performed on samples from the proband's parents indicated that the father had the same FY genotype as the fetus. Flow cytometry, which has been previously demonstrated as a useful method to study antigen strength on cells, was used to determine if this new FY*01 allele was associated with reduced Fy(a) expression on the father's RBCs. Median fluorescence intensity of the father's RBCs (after incubation with anti-FY(a) and fluorescein-labeled anti-IgG) was similar to known FY*01 heterozygotes. and significantly weaker than known FY*01 homozygotes. In conclusion, the fetus and father both had one normal FY*01 allele and one new FY*01W.01, is associated with weakened expression of Fy(a) on RBCs.


Asunto(s)
Sistema del Grupo Sanguíneo Duffy/genética , Eritrocitos/metabolismo , Enfermedades Fetales/sangre , Talasemia alfa/sangre , Alelos , Salud de la Familia , Citometría de Flujo , Genotipo , Técnicas de Genotipaje/métodos , Humanos , Masculino , Fenotipo , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Polimorfismo de Nucleótido Simple
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA